Clinical effects of standard and heparin-coated circuits on coagulation and fibrinolysis during cardiopulmonary bypass

Japanese Journal of Artificial Organs

Volumn 25, Issue 3, 1996, Pages 649-654

  Hattori, K ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cardiopulmonary bypass; coagulation; fibrinolysis; heparin coated circuit

Indexed keywords

HEPARIN;

ARTICLE; BLOOD CLOTTING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FIBRINOLYSIS; HEPARINIZATION; HUMAN; OXYGENATOR; PARTIAL THROMBOPLASTIN TIME; TREATMENT OUTCOME;

EID: 0029799444     PISSN: 03000818     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hashimoto K, Yamagishi M, Sasaki T, Nakao M, Kurosawa H : Heparin and antithrombin III levels during cardiopulmonary bypass: Correlation with subclinical plasma coagulation. Ann Thorac Surg 58 : 799, 1994
2. Wagner WR, Johnson PC, Thompson KA, Marrone GC : Heparin-coated cardiopulmonary bypass circuits : Hemostatic alterations and postoperative blood loss. Ann Thorac Surg 58 : 734, 1994
3. Valen G, Eriksson E, Risberg B, Vaage J : Fibrinolysis during cardiac surgery. Ralease of tissue plasminogen activator in arterial and coronary sinus blood. Eur J Cardiothorac Surg 8 : 324, 1994
4. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M, Deguchi K : Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothorac Anesth 3 : 181, 1989
5. Edmunds LH Jr : Blood-surface interactions during cardiopulmonary bypass. J Card Surg 8 : 404, 1993
6. Burman JF, Chung HI, Lane DA, Philippou H, Ademi A, Lincoln JC : Role of factor XII in thrombin generation and fibririolysis during cardiopulmonary bypass. Lancet 344 : 1192, 1994
7. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, Smith KJ : Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 82 : 3350, 1993
8. 12) Medical Practice 8 : 6, 1991
9. van der Kamp KW, van Oeveren W : Contact, coagulation and platelet interaction with heparin treated equipment during heart surgery. Int J Artif Organs 16 : 836, 1993
10. Gravlee GP, Haddon WS, Rothberger HK, Mills SA, Rogers AT, Bean VE, Buss DH, Prough DS, Cordell AR : Heparin dosing and monitoring for cardiopulmonary bypass. A comparson of techniques with measurement of subclinical plasma coagulation. J Thorac Cardiovasc Surg 99 : 518, 1990
11. Kongsgaard UE, Smith-Erichsen N, Geiran O, Bjornskau L : Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 37 : 158, 1989
12. Stibbe J, Kluft C, Brommer EJ, Gomes M, & Jong DS, Nauta J : Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue type) plassminogen activator. Eur J Clin Invest 14 : 375, 1984